Dr. George Shapiro | Source | Chief Medical Officer at Organicell Regenerative Medicine
Dr. George Shapiro
Chief Medical Officer at Organicell Regenerative Medicine
On the record
Represented by:
Recent Quotes
Sign up to view all
-
The six outpatients with different stages of COVID-19 were treated with Zofin under an emergency investigational new drug expanded access program, with physicians for all six patients reporting significant improvement.
9 November 2020
Media
Sign up to view all
-
9 November 2020article
Three New COVID-19 Patients Treated with Zofin™ Report ImprovementOrganicell announces three new COVID-19 patients treated with Zofin report improvement. Organicell commences Phase I/II clinical trial enrollment.
Employment
Sign up to view all
-
Organicell Regenerative Medicine
Chief Medical Officer